Skip to main content
AGL logo

agilon health, inc. (AGL) Stock: Price, Forecast & Analyst Target

agilon health, inc. (AGL) — MoonshotScore 36/100 (Weak band), calculated Nov 18, 2026. Price $90.24 (+0.83%), as of the Nov 20, 2026 trading session; market cap $1.52B.

Educational signal · not a buy or sell recommendation · How to read this

$90.24 +$0.74 (+0.83%) Market Cap $1.52B

agilon health, inc. · AGL · NYSE

Agilon Health, Inc. operates within the healthcare sector, focusing on providing services to seniors through primary care physicians.

Price as of Nov 20, 2026

Key Statistics

36 of 100

MoonshotScore v2 · agilon health (AGL)

Weak
Business Quality Average (49)
Financial Safety Fragile (19)
Valuation Fair (73)
Growth Durability Growing (68)
Momentum Surging (97)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Durable growth, but a fragile balance sheet. The score also carries a risk penalty for losses on top of negative retained earnings. Business Quality: Average; Financial Safety: Fragile; Valuation: Fair; Growth Durability: Growing; Momentum: Surging.

  • EPS beat 3 of the last 4 reports
  • Altman Z 2.95 · Piotroski F 4
  • ROE -36.2% · ROA -3.9% · current ratio 1.14

Holding back: balance-sheet strain

Helping: an attractive price, durable growth, positive momentum

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for AGL (58 recorded, newest six shown)
RecordedScoreBand
36Weak
35Weak
35Weak
36Weak
36Weak
36Weak

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$90.24
Change on the day+0.83%
Market capitalisation$1.52B—
Price / earnings (trailing)-2.45
Shares traded on the day266.3K

Price & events

Other perspectives

Council score for agilon health (AGL): perspectives

Some lenses disagree with the MoonshotScore. Compare their readings below; each uses a different method.

5-Factor Breakdown

Business Quality Neutral
Financial Safety Negative
Valuation Moderate
Growth Durability Moderate
Momentum Strong

Legends Council

4 lenses, 4 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Griffin-style lens (simulated) Ken Griffin Favorable read
Englander-style lens (simulated) Izzy Englander Unfavorable read
Klarman-style lens (simulated) Seth Klarman Unfavorable read
Moon AI lens (model) Unfavorable read

Read on: Nov 20, 2026

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Weak
Margin of Safety Fairly Valued
Profit Margin Weak
Revenue Growth Negative
Debt/Equity Moderate
ROE Negative
Gross Margin Negative

Read on: Nov 19, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

One of these lenses reads this company more favourably than the MoonshotScore does: Griffin-style lens. Each lens is a separate scoring function over its own inputs, so a disagreement is a difference of method rather than a correction — the page's answer stays the MoonshotScore above.

On Nov 19, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.

Readings on this page are from Nov 21, 2026, except a card that shows its own read date.

1 · What is it?

What is agilon health (AGL), and what does it report?

Short answer

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. agilon health, inc. (AGL) is listed on NYSE. It employs 856 people. The market values it at $1.52B.

2 · Latest results

What do the latest results show for agilon health (AGL)?

Short answer · as of

Against analyst estimates the company has EPS beat 3 of the last 4 reports.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Sep 2025$1.44B-$110M-$6.65 (diluted)
Q4 FY2025$1.57B-$189M-$11.39 (diluted)
Q1 FY2026$1.42B$49M$2.94 (diluted)
Q2 FY2026$1.49B$18M$1.04 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for agilon health (AGL)?

Short answer

The MoonshotScore pillars rate an attractive price, durable growth, positive momentum as strengths. What is holding it back is balance-sheet strain. The distress and quality screens read Altman Z 2.95 · Piotroski F 4. Trailing ratios: ROE -36.2% · ROA -3.9% · current ratio 1.14.

4 · What to check next?

What should you watch next at agilon health (AGL)?

Short answer · as of

Current published price targets run low $111.00 · high $146.00 · consensus $122.50 · median $120.50 against a quoted price of $90.24 (as of Nov 20, 2026).

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.
  • The next earnings date is not yet scheduled in the calendar we read.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does agilon health compare with its peers?

Short answer

agilon health's score ranks 12th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Healthcare Services Group, Inc. (HCSG) Same industry, near in market value$24.72 Nov 20, 2026$1.67B93 5-pillar Nov 18, 2026
AMN Healthcare Services, Inc. (AMN) Same industry, near in market value$35.68 Nov 20, 2026$1.38B93 5-pillar Nov 18, 2026
Addus HomeCare Corporation (ADUS) Same industry, near in market value$121.07 Nov 19, 2026$2.26B93 5-pillar Nov 18, 2026
InnovAge Holding Corp. (INNV) Same industry, near in market value$9.16 Nov 20, 2026$1.25B92 5-pillar Nov 18, 2026
Pediatrix Medical Group, Inc. (MD) Same industry, near in market value$30.22 Nov 20, 2026$2.36B82 5-pillar Nov 18, 2026
Ardent Health Partners, LLC (ARDT) Same industry, near in market value$15.08 Nov 20, 2026$2.10B81 5-pillar Nov 18, 2026
Astrana Health, Inc. (ASTH) Same industry, near in market value$28.90 Nov 20, 2026$1.44B80 5-pillar Nov 18, 2026
National HealthCare Corporation (NHC) Same industry, near in market value$188.55 Nov 19, 2026$2.95B76 5-pillar Nov 18, 2026
Aveanna Healthcare Holdings Inc. (AVAH) Same industry, near in market value$11.01 Nov 20, 2026$2.40B75 5-pillar Nov 18, 2026
The Pennant Group, Inc. (PNTG) Same industry, near in market value$34.64 Nov 20, 2026$1.22B68 5-pillar Nov 18, 2026
U.S. Physical Therapy, Inc. (USPH) Same industry, near in market value$95.93 Nov 20, 2026$1.43B63 5-pillar Nov 18, 2026
agilon health (AGL) — this page$90.24$1.52B36
Acadia Healthcare Company, Inc. (ACHC) Same industry, near in market value$34.47 Nov 19, 2026$3.20B28 5-pillar Nov 18, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

The records behind this page

Analyst targets & estimates

What analysts have on file

Price target, low to high
$111.00 – $146.00
Consensus target
$122.50
Median target
$120.50

Consensus record · Captured .

Measured against a quoted price of $90.24 (as of Nov 20, 2026).

Insider activity

Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Aug 16, 2026

Transactions
10
Identified insiders
9
Purchases
0
Sales
0
Other transactions
10

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held AGL in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported AGL in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about agilon health (AGL)?

Read these with our analysis →

Common Questions About AGL

These answers are editorial: 1 of these 9 answers is drawn from the AGL research dossier (written May 10, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for AGL?

AGL carries the MoonshotScore stated above — the Weak band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Is AGL a good stock to buy?

Stock Expert AI does not rate AGL buy, sell or hold. agilon health, inc. carries a MoonshotScore, in the Weak band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the AGL stock price today?

The last price recorded for agilon health, inc. (AGL), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the AGL price target?

The analyst consensus price target for agilon health, inc. (AGL), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.

What does Agilon Health, Inc. do?

Agilon Health, Inc. operates as a healthcare service provider focused on seniors, partnering with primary care physicians across the United States.

What are the key factors to evaluate for AGL?

agilon health, inc. (AGL) holds a MoonshotScore in the low range. To weigh it, read the analyst view under Analyst targets & estimates on this page. Strategic Partnerships and Acquisitions: Agilon can pursue strategic partnerships and acquisitions to expand its capabilities and reach. Not financial advice.

How frequently does AGL data refresh on this page?

AGL's price is the last quote we recorded, from the Nov 20, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven AGL's recent stock price performance?

agilon health, inc. (AGL) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established network of primary care physician partners. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider AGL overvalued or undervalued right now?

agilon health, inc. (AGL) is loss-making, so its trailing P/E (listed under Price & valuation) is negative and not usable for valuation — lean on price-to-sales and cash flow in the Financials tab. Its analyst consensus target is listed under Analyst targets & estimates on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 16 figures on this page — 12 from Financial Modeling Prep (FMP), 3 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.